<DOC>
	<DOCNO>NCT00909038</DOCNO>
	<brief_summary>It national , retrospective , observational study hypertensive patient treat least 8 week fix dose combination telmisartan 80 mg hydrochlorothiazide 25 mg . The primary objective ass control rate ( systolic diastolic blood pressure ) . Key secondary objective assess blood pressure reduction least 8 week treatment , describe population treat new fix dose combination</brief_summary>
	<brief_title>Telmisartan 80mg+Hydrochlorothiazide ( HCTZ ) 25 mg Hypertension : Observational Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Inclusion criterion : Hypertensives Treated least 8 week fix dose combination telmisartan 80 mg hydrochlorothiazide 25 mg Exclusion criterion : Treated combination less 8 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>